1. Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
- Author
-
Sonpavde, Guru, Khan, Myrna M., Svatek, Robert S., Lee, Richard, Novara, Giacomo, Tilki, Derya, Lerner, Seth P., Amiel, Gilad E., Skinner, Eila, Karakiewicz, Pierre I., Bastian, Patrick J., Kassouf, Wassim, Fritsche, Hans-Martin, Izawa, Jonathan I., Ficarra, Vincenzo, Dinney, Colin P., Lotan, Yair, Fradet, Yves, and Shariat, Shahrokh F.
- Subjects
- *
BLADDER cancer , *NOMOGRAPHY (Mathematics) , *TRANSITIONAL cell carcinoma , *LYMPH nodes , *MULTIVARIATE analysis , *DRUG therapy - Abstract
Study Type - Therapy (individual cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Patients with urothelial carcinoma of the bladder (UCB) and pathological (p) stage T2N0 disease exhibit a range of clinical outcomes with an overall estimated 10-25% experiencing recurrence and death after radical cystectomy (RC). Nomograms to prognosticate UCB post-RC have been developed in heterogeneous datasets of patients across different stages and do not address factors unique to pT2N0 disease. A user-friendly prognostic risk model was devised for patients with pT2N0 UCB undergoing RC based on residual pathological stage at RC (pT2a, pT2b,
- Published
- 2011
- Full Text
- View/download PDF